Latest filings (excl ownership)
8-K
Regulation FD Disclosure
3 Oct 24
424B5
Prospectus supplement for primary offering
2 Oct 24
8-K
Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
2 Oct 24
8-K
Monogram Technologies Announces Preferred Stock Dividends
30 Sep 24
8-K
Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million
11 Sep 24
424B5
Prospectus supplement for primary offering
11 Sep 24
8-K
Other Events
19 Aug 24
10-Q
2024 Q2
Quarterly report
15 Aug 24
NT 10-Q
Notice of late quarterly filing
14 Aug 24
8-K
Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration
12 Aug 24
8-K
Regulation FD Disclosure
8 Aug 24
424B5
Prospectus supplement for primary offering
22 Jul 24
8-K
Entry into a Material Definitive Agreement
22 Jul 24
8-K
Entry into a Material Definitive Agreement
12 Jul 24
424B5
Prospectus supplement for primary offering
9 Jul 24
424B5
Prospectus supplement for primary offering
1 Jul 24
424B5
Prospectus supplement for primary offering
25 Jun 24
424B5
Prospectus supplement for primary offering
25 Jun 24
EFFECT
Notice of effectiveness
17 Jun 24
S-3
Shelf registration
3 Jun 24
1-A-W
Offering statement withdrawal
3 Jun 24
424B3
Prospectus supplement
17 May 24
8-K
Monogram Orthopaedics Completes Corporate Name Change to Monogram Technologies
15 May 24
8-K
Monogram Orthopaedics Reports First Quarter 2024 Financial Results
14 May 24
10-Q
2024 Q1
Quarterly report
13 May 24
1-A/A
Offering in Equity
8 May 24
8-K
Monogram Provides Regulatory Update Following Meeting with FDA
1 May 24
EFFECT
Notice of effectiveness
1 May 24
424B3
Prospectus supplement
30 Apr 24
POS AM
Prospectus update (post-effective amendment)
18 Apr 24
8-K
Other Events
18 Apr 24
1-A
Offering in Equity
26 Mar 24
8-K
Regulation FD Disclosure
21 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
15 Mar 24
8-K
Monogram Orthopaedics Reports Full Year 2023 Financial Results
15 Mar 24
10-K
2023 FY
Annual report
14 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
5 Dec 23
424B3
Prospectus supplement
8 Nov 23
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Regulation FD Disclosure
20 Oct 23